Abbot is releasing essentially an identical platfo
Post# of 22453
(Total Views: 512)
Posted On: 01/02/2021 2:19:36 PM
Abbot is releasing essentially an identical platform to Innova/QD healthID that will allow test results to be stored and proven Abbot calls it a "Navica Pass"
https://www.abbott.com/BinaxNOW-Test-NAVICA-A...A-FAQ.html
Not hype just facts. When some say QMC Health ID will never happen and yet Innova has QDX Health prominently displayed on their website and obviously see a benefit to adding it to their ecosystem.
https://www.innovamedgroup.com/qdx-healthid
Our partner Innova who has recently procured over a billion $ in sales to the UK.
QMC health ID has privacy protection
https://www.qmchealthid.com/
You have control over the privacy of your health information information
Only you can share your health status with others
Your clinical information is maintained separately from the mobile device and app
All health status and clinical information is subject to GDPR, healthcare data standards as well as “forget my data” regulations
You can opt-out at any time
https://www.abbott.com/BinaxNOW-Test-NAVICA-A...A-FAQ.html
About the BinaxNOW COVID-19 Ag Card Home Test and NAVICA App
The BinaxNOW™ COVID-19 Ag Card Home Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2. This test is authorized for prescription home use with self-collected observed direct anterior nasal (nares) swab samples from individuals aged 15 years or older who are suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset or adult collected nasal swab samples from individuals aged four years or older who are suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset. The BinaxNOW COVID-19 Ag Card Home Test is to be performed only with the supervision of a telehealth proctor.
Along with BinaxNOW, Abbott is also offering a mobile app at no charge called NAVICA, which will allow people to display their results obtained through a healthcare provider or through the eMed at-home service when entering facilities requiring proof of testing. The NAVICA app is optional and an easy-to-use tool that allows people to store, access and display their results with organizations that accept the results so people can move about with greater confidence. The NAVICA app is supported by Apple and Android digital wallets and is available from public app stores in the U.S.
https://youtu.be/dXWDYgSWv_k
https://www.abbott.com/BinaxNOW-Test-NAVICA-A...A-FAQ.html
Not hype just facts. When some say QMC Health ID will never happen and yet Innova has QDX Health prominently displayed on their website and obviously see a benefit to adding it to their ecosystem.
https://www.innovamedgroup.com/qdx-healthid
Our partner Innova who has recently procured over a billion $ in sales to the UK.
QMC health ID has privacy protection
https://www.qmchealthid.com/
You have control over the privacy of your health information information
Only you can share your health status with others
Your clinical information is maintained separately from the mobile device and app
All health status and clinical information is subject to GDPR, healthcare data standards as well as “forget my data” regulations
You can opt-out at any time
https://www.abbott.com/BinaxNOW-Test-NAVICA-A...A-FAQ.html
About the BinaxNOW COVID-19 Ag Card Home Test and NAVICA App
The BinaxNOW™ COVID-19 Ag Card Home Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2. This test is authorized for prescription home use with self-collected observed direct anterior nasal (nares) swab samples from individuals aged 15 years or older who are suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset or adult collected nasal swab samples from individuals aged four years or older who are suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset. The BinaxNOW COVID-19 Ag Card Home Test is to be performed only with the supervision of a telehealth proctor.
Along with BinaxNOW, Abbott is also offering a mobile app at no charge called NAVICA, which will allow people to display their results obtained through a healthcare provider or through the eMed at-home service when entering facilities requiring proof of testing. The NAVICA app is optional and an easy-to-use tool that allows people to store, access and display their results with organizations that accept the results so people can move about with greater confidence. The NAVICA app is supported by Apple and Android digital wallets and is available from public app stores in the U.S.
https://youtu.be/dXWDYgSWv_k
(0)
(0)Quantum Materials Corp. (QTMM) Stock Research Links
Scroll down for more posts ▼